Neurocrine Biosciences EBIT 2010-2024 | NBIX

Neurocrine Biosciences EBIT for the quarter ending September 30, 2024 was $0.184B, a 30.17% increase year-over-year.

  • Neurocrine Biosciences 2023 EBIT was 0.251B, a 0.76% increase from 2022.
  • Neurocrine Biosciences 2022 EBIT was 0.249B, a 142.93% increase from 2021.
  • Neurocrine Biosciences 2021 EBIT was 0.103B, a 37.12% decline from 2020.

EBIT can be defined as earnings before interest and taxes.

Neurocrine Biosciences EBIT 2010-2024 | NBIX

  • Neurocrine Biosciences 2023 EBIT was 0.251B, a 0.76% increase from 2022.
  • Neurocrine Biosciences 2022 EBIT was 0.249B, a 142.93% increase from 2021.
  • Neurocrine Biosciences 2021 EBIT was 0.103B, a 37.12% decline from 2020.

EBIT can be defined as earnings before interest and taxes.